Four years of long-term data confirm the continued safety of the drug tildrakizumab in patients with psoriatic arthritis.
Christopher Ritchlin, MD, MPH
Advertisement
Articles by Christopher Ritchlin, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Clinicians Cite Progress Tracking as Top Barrier in Value-Based Care
2
T-DXd Delivers Strong Breast Cancer Outcomes Across Groups
3
Camizestrant-Related Photopsia Mostly Mild, Nondisabling in Patients With Advanced Breast Cancer: Adam Brufsky, MD, PhD
4
Genome-Wide Analysis Uncovers Genetic Drivers of IPF and Its Overlap With COVID-19
5
